News & Impact Stories at Columbia SPS
News at Columbia SPS
Anam Khan of Strategic Communications: Are we resilient or just forgetful?
Khan pens an op-ed that explores whether muted reactions to the atrocities in Pakistan signal callousness or courage.
Bioethics Program Director Discusses the Troubling Implications of Genetic Sequencing
Robert Klitzman speaks about ethical concerns with regard to genome sequencing.
2014’s Best Videos from the School of Professional Studies
SPS hosted events series that were free and open to the public.
Alumna Kat Read Facilitates Positive Change at Doctors Without Borders
The recent Nonprofit Management grad talks about her mission-driven work at the international medical humanitarian organization.
Strategic Communications Workshop: How to Run a Killer Meeting
The key to a killer meeting is preparation, easy communication, and the incorporation of fun.
Getting Into Graduate School: What Do Admissions Directors Seek in an Application?
Columbia administrators discussed the attributes they seek in successful applicants.
On HuffPost Live, Robert Klitzman Addresses the Ethical Issues That Surround Discussions of Ebola
Dr. Robert Klitzman and panel on HuffPost Live addressed Ebola and proposed travel bans.
Careers in Bioethics: Jonathan Haidt Discusses Sanctity Versus Care
Bioethics students and members of the Columbia community gathered to hear a lecture by Jonathan Haidt.
Amy Arbus Explores the Intersection of Visual Art, Mental Health, and Narrative Medicine
The editorial and commercial photographer discussed healing, art, and the art of healing.
Robert Klitzman Explores the Connection Between Culture, Rituals, and Disease Transmission
Stopping the spread of Ebola entails a new dilemma -- challenging long-standing rituals of an at-risk community.
Bioethics Director Robert Klitzman on the Spiritual Needs of Cancer Patients
Where does spirituality fit into medical practice? To find out, Medscape spoke with Bioethics program director Robert Klitzman.
Bioethics Director Comments on the Ethics of Treating Ebola with Experimental Drugs
From an ethical perspective, can clinicians treat the fast-spreading Ebola virus with experimental drugs?